Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frytak

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
CA: a Cancer Journal for Clinicians|September 1, 1980
Is THC an effective antiemetic for cancer patients? Opinion 1S Frytak
American Journal of Clinical Oncology|June 1, 1997
Mitomycin lung toxicity. Acute and chronic phasesS H Okuno, S Frytak
JAMA|January 23, 1981
Management of nausea and vomiting in the cancer patientS Frytak, C G Moertel
The Journal of Urology|April 1, 1997
The case of the phantom bladderR Fonseca, S Frytak, B Mokri
American Journal of Clinical Oncology|April 1, 1997
Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosisR Kochhar, S Frytak, E G Shaw
Cancer|May 1, 1997
Extrapulmonary small cell carcinomaE Galanis, S Frytak, R V Lloyd
Cancer Treatment Reports|December 1, 1984
Metabolic studies of delta-9-tetrahydrocannabinol in cancer patientsS Frytak, C G Moertel, J Rubin
Annals of Internal Medicine|March 1, 1978
Neurologic toxicity associated with high-dose metronidazole therapyS Frytak, C H Moertel, D S Childs
Cancer Investigation|January 1, 1985
Continuous five-drug versus alternating three-drug and two-drug chemotherapy after five-drug or three-drug induction in extensive small cell lung cancerR T Eagan, S Frytak, E T Creagan, et al.
The Journal of Investigative Dermatology|December 1, 1990
Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigationsE T Creagan, D J Schaid, D L Ahmann, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
CA: a Cancer Journal for Clinicians|September 1, 1980
Is THC an effective antiemetic for cancer patients? Opinion 1S Frytak
American Journal of Clinical Oncology|June 1, 1997
Mitomycin lung toxicity. Acute and chronic phasesS H Okuno, S Frytak
JAMA|January 23, 1981
Management of nausea and vomiting in the cancer patientS Frytak, C G Moertel
The Journal of Urology|April 1, 1997
The case of the phantom bladderR Fonseca, S Frytak, B Mokri
American Journal of Clinical Oncology|April 1, 1997
Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosisR Kochhar, S Frytak, E G Shaw
Cancer|May 1, 1997
Extrapulmonary small cell carcinomaE Galanis, S Frytak, R V Lloyd
Cancer Treatment Reports|December 1, 1984
Metabolic studies of delta-9-tetrahydrocannabinol in cancer patientsS Frytak, C G Moertel, J Rubin
Annals of Internal Medicine|March 1, 1978
Neurologic toxicity associated with high-dose metronidazole therapyS Frytak, C H Moertel, D S Childs
Cancer Investigation|January 1, 1985
Continuous five-drug versus alternating three-drug and two-drug chemotherapy after five-drug or three-drug induction in extensive small cell lung cancerR T Eagan, S Frytak, E T Creagan, et al.
The Journal of Investigative Dermatology|December 1, 1990
Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigationsE T Creagan, D J Schaid, D L Ahmann, et al.
Pageof 11